SEC documents submitted by Great Point Partners, LLC on May 31, 2024 show that they hold a passive equity interest of 9.89% in Context Therapeutics.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.